News
Zacks.com on MSN58m
JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?JNJ edges out AZN following Q2 results with raised guidance, stronger estimate revisions and a more attractive valuation.
NEW YORK (Reuters) -With more than half of second quarter earnings reported and stocks near record highs, company results ...
38m
Aemetis Inc. company and executive profile by Barron's. View the latest AMTX company infomation and executive bios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback